CV Science

Alexandre Escargueil PhD in Molecular and Cellular Biology

Course and current status

Current positions

Since 2023: Co-coordinator of the "Global Approach to Health" program ("SOUND - SOrbonne University for a New Deal" project) – Alliance Sorbonne Université.

Since 2022: Scientific coordinator of the French-Indian Campus "Integrated Health" – Sorbonne Université/Indian Institute of Technology Delhi.

Since 2022: Director Education Institute of Oncology – APHP.6-Sorbonne University, Paris, France.

Since 2020: Head and co-Founder of the Biomedical Humanities Initiative – Sorbonne University, Paris, France.

Since 2015: Head and Founder of the Bachelor Degree in Innovative Public Health Science – Faculty of Science and Engineering, Sorbonne University, Paris, France.

Since 2014: Full Professor in Cell Biology and Genetics (Sorbonne University), Research Centre Saint-Antoine – INSERM UMR_S 938 & SU Paris, France

Previous positions

2014-2023: Co-head and co-Founder  of the Interdisciplinary Ph.D. Program in Oncology – Institute of Oncology – Faculty of Medicine, Sorbonne University, Paris, France.

2008-2014: Assistant Professor in Cell Biology and Genetics (University Pierre et Marie Curie), Research Centre Saint-Antoine – INSERM UMR_S 938 & UPMC Paris, France.

2007-2008: Visiting Professor – Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

2004-2007: Post-doctoral Fellow – INSERM U673, Hospital Saint-Antoine, Paris, France

2001-2004: Post-doctoral Fellow – University of Oxford, Sir William Dunn School of pathology, Oxford, United-Kingdom.

2000-2001: Military Service – Commissariat à l'Energie Atomique, Gif-sur-Yvette, France.

1995-2000: Ph. D. student – Institute Gustave-Roussy, Villejuif, France.

Current editorial activity

Since 2020: Editor-in-Chief, section "Cancer Therapy" – Cancers (ISSN: 2072-6694).

Since 2019: Member of the Editorial Board – Cancers (ISSN: 2072-6694).

Since 2016: Member of the International Editorial Board – Tumori Journal (ISSN: 0300-8916).

Since 2022: Coordinator Life Sciences & Health – COFECUB.

Since 2021: Member of the Board of Directors – Sorbonne University.

Since 2019: Member of the Board for strategic guidance of the Institute of Oncology – APHP.6-Sorbonne University.

Scientific summary

My work is focused on the interplay between cancer biology and therapeutics. It concerns the development of novel anticancer agents and combinations and their associated biomarkers based on a mechanistic understanding. This includes both DNA-targeted agents and drugs targeting oncogenic signaling pathways.